Profile data is unavailable for this security.
About the company
Zentek Ltd. is a Canada-based graphene technology company. The principal business of the Company is to develop opportunities in the graphene and related nano-materials industry based on its intellectual property, patents and unique Albany graphite. The Company is focused on the research, development, and commercialization of graphene-based products. The Company's technology helps filter and deactivate pathogens to reduce the risk of transmission. The Company is focused on commercializing ZenGUARD, which is a hydrophilic, water attracting coating that adsorbs bacteria and virus-laden aerosols and deactivates them, increasing public safety, and reducing the risk of transmission of COVID and other pathogens. The Company is developing a graphene-based fuel additive that can reduce greenhouse gas (GHG) emissions from diesel and bio-diesel fuels. The Company’s developments include Aptamers & Rapid Detection and Graphene-Oxide Synthesis & Graphene Synthesis.
- Revenue in CAD (TTM)33.61k
- Net income in CAD-11.98m
- Incorporated2008
- Employees27.00
- LocationZentek Ltd24 Corporate CtGUELPH N1G 5G5CanadaCAN
- Phone+1 (705) 618-0900
- Fax+1 (705) 618-0900
- Websitehttps://www.zentek.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oncolytics Biotech Inc | 0.00 | -28.21m | 103.33m | 29.00 | -- | 4.50 | -- | -- | -0.4027 | -0.4027 | 0.00 | 0.3046 | 0.00 | -- | -- | -- | -80.51 | -81.99 | -88.84 | -97.25 | -- | -- | -- | -- | -- | -- | 0.0468 | -- | -- | -- | -11.75 | -- | -40.52 | -- |
Arch Biopartners Inc | 1.50m | -2.14m | 105.35m | -- | -- | -- | -- | 70.24 | -0.0341 | -0.0341 | 0.024 | -0.1025 | 0.5472 | -- | 0.6897 | -- | -78.01 | -214.82 | -- | -- | -- | -- | -142.55 | -180.45 | -- | -4.06 | -- | -- | 105.63 | -- | -136.30 | -- | -- | -- |
Sernova Corp | 0.00 | -41.32m | 106.26m | -- | -- | -- | -- | -- | -0.1362 | -0.1362 | 0.00 | -0.0181 | 0.00 | -- | -- | -- | -165.95 | -74.84 | -303.82 | -85.03 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -59.69 | -- | -2.91 | -- |
Biosyent Inc | 32.84m | 7.05m | 117.91m | 0.00 | 17.08 | 3.36 | 15.69 | 3.59 | 0.5856 | 0.5856 | 2.72 | 2.97 | 0.8341 | 1.23 | 10.80 | -- | 17.92 | 14.77 | 20.00 | 16.92 | 80.41 | 79.74 | 21.48 | 19.99 | 6.37 | -- | 0.0329 | 9.26 | 13.12 | 7.97 | 18.35 | 2.52 | -2.67 | -- |
Eupraxia Pharmaceuticals Inc | 0.00 | -41.78m | 126.83m | 29.00 | -- | 4.75 | -- | -- | -1.65 | -1.65 | 0.00 | 0.7492 | 0.00 | -- | -- | 0.00 | -122.29 | -127.84 | -185.74 | -935.99 | -- | -- | -- | -- | -- | -85.63 | 0.3455 | -- | -- | -- | -52.63 | -- | -7.69 | -- |
Spectral Medical Inc | 1.74m | -17.93m | 133.18m | 29.00 | -- | -- | -- | 76.72 | -0.0643 | -0.0647 | 0.0062 | -0.0721 | 0.2507 | 3.23 | 2.19 | 59,862.07 | -258.89 | -109.65 | -18,581.35 | -175.35 | 37.85 | 63.74 | -1,032.89 | -445.72 | 0.3287 | -2.56 | -- | -- | -4.14 | -16.08 | -104.12 | -- | 31.53 | -- |
Zentek Ltd | 33.61k | -11.98m | 139.13m | 27.00 | -- | 6.19 | -- | 4,139.57 | -0.1197 | -0.1197 | 0.0003 | 0.2228 | 0.0013 | 0.0796 | 0.0876 | 1,244.82 | -44.53 | -41.94 | -48.53 | -44.46 | -573.70 | -- | -35,636.60 | -12,771.31 | 4.27 | -- | 0.0538 | -- | -79.01 | -- | 54.52 | -- | 39.27 | -- |
Medicenna Therapeutics Corp | 0.00 | -15.42m | 155.24m | 18.00 | -- | 7.74 | -- | -- | -0.2215 | -0.2215 | 0.00 | 0.2675 | 0.00 | -- | -- | -- | -50.19 | -48.65 | -56.66 | -54.45 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 55.49 | -- | -- | -- |
NervGen Pharma Corp | 0.00 | -20.02m | 174.82m | 10.00 | -- | 9.29 | -- | -- | -0.3363 | -0.3363 | 0.00 | 0.2692 | 0.00 | -- | -- | -- | -78.68 | -121.15 | -138.24 | -180.20 | -- | -- | -- | -- | -- | -9.07 | 0.0092 | -- | -- | -- | -8.01 | -- | 2.20 | -- |